Search results
Added:
1 month ago
Dr Marco Schiavone (Centro Cardiologico Monzino IRCCS, Milan, IT) and Dr Claudio Tondo (Monzino Cardiologic Centre, Milan, IT) discuss long-term durability data from an 8-year follow-up study of cryoballoon pulmonary vein isolation for atrial fibrillation.In this Journal Club session, the experts dig into real-world evidence on the extended durability of cryoballoon ablation, tackling key…
View more
Added:
1 year ago
TCT Conference 2024 - Significant reduction in TLF and TVF and flattening of event curves after 6 months in favour of DynamX Bioadaptor.Dr David Erlinge (Skane University Hospital, Lund, SE) joins us onsite at TCT Conference to discuss the findings from INFINITY-SWEDEHEART (NCT04562805).INFINITY-SWEDEHEART is a prospective, multicenter, randomized registry-based clinical trial, where patients…
View more
Added:
1 month ago
Source:
Radcliffe Cardiology
Therapies for transthyretin amyloidosis with cardiomyopathy (ATTR-CM), including transthyretin (TTR) stabilisers and silencers, have demonstrated a mortality benefit in randomised trials. However, the timing of this benefit has been a subject of debate. A new analysis of three major outcomes trials has evaluated this time course, revealing a consistent pattern across different treatments…
View more
Oxidative Stress Genes Predict Survival in STEMI
Added:
12 months ago
Original Research
Added:
8 months ago
Expert interventionalists, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) discuss the most anticipated hot line studies to be unveiled at ESC Congress 2025. Tune in for their in-depth analysis to get ahead of the curve.ESC Congress 2025 Hot Line Trials Discussed:00:25 DOUBLE-CHOICE03:03 VANTAGE05:03 VICTOR06:28 VICTORIA07:58 DIGIT HF10:19 DAPA ACT HF-TIMI…
View more
Added:
5 months ago
TCT 2025 - Sub-anlysis findings showed positive safety and efficacy outcomes of the PASCAL Precision system in degenerative mitral regurgitation (DMR) patients.Dr P Kasi Ramanathan (Promedica Toledo Hospital, OH, US) joins us on-site at TCT 2025 to share the findings from a sub-analysis looking at the affect of implant location and leaflet lesion location on the safety and effectiveness of the…
View more
Added:
1 year ago
Which trials will have the greatest impact at TCT 2024?Get a head start on the biggest cardiovascular breakthroughs of TCT 24! Leading experts Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) offer an exclusive preview of the most anticipated late-breaking studies set to be unveiled at TCT Conference 2024. Discover their in-depth analysis of these studies and…
View more
Added:
7 months ago
Discover the rapidly evolving therapeutic options transforming outcomes for cardiac amyloidosis patients with Dr Sarah Cuddy.This comprehensive presentation, part of the Cardiomyopathies track, explores the dramatic advances in both TTR and AL amyloidosis treatment over the past decade. Dr Cuddy examines how modern therapeutic approaches have fundamentally shifted survival curves, particularly…
View more
Added:
1 year ago
Which interventional cardiology studies will have the greatest impact at ESC 2024?Leading experts Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) offer an exclusive preview of the most anticipated hot line studies set to be unveiled at ESC Congress 2024. Get their in-depth analysis of the studies and gain invaluable insights ahead of the curve.ESC Congress…
View more
TCT 2024 Late-Breaking Science Collection
Added:
1 year ago
Video Series